Drug Injury Watch: Personal Injury Law

Home -> Law Blog Directory -> Personal Injury Law Blogs

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Personal Injury Law

Drug Injury Watch

Provides developing information about prescription drug side effects as well as up-to-date news from the legal, medical, FDA, and pharmaceutical sectors.
By Tom Lamb

Post Frequency: 0.9/day

Last Entry: October 30, 2020 at 16:30:00

NuvaRing Update: First Trial Dates In MDL And New Jersey Mass Tort Litigation Not Until 2012, Now

Posted on December 16, 2010
Discovery Deadlines And Expert Witness Deposition Dates Are Extended To Allow Time For Additional Document Review (Posted by Tom Lamb at DrugInjuryWatch.com) We learned in April 2010 from U.S. District Judge Rodney W. Sippel, who is presiding over the NuvaRing federal court MDL, that the trial for the first of several bellwether, or test, cases in the NuvaRing MDL was scheduled to start in June 2011...

Prempro Litigation Report: Here Is A Tale of Two Very Different Recent Case Outcomes

Posted on December 09, 2010
As Of December 2010 The Fourteen Jury Verdicts Are Evenly Split Between Defendant Pfizer And Plaintiffs (Posted by Tom Lamb at DrugInjuryWatch.com) We will start with the more recent case, Torkie-Tork v. Wyeth, 04-cv-945, U.S. District Court for the Eastern District of Virginia (Alexandria)...

Use Of Avastin Or Sutent And I.V. Bisphosphonates May Increase Osteonecrosis Of Jaw (ONJ) Risk

Posted on December 01, 2010
MHRA Warns UK Doctors To Monitor Cancer Patients For ONJ Where There Is Concomitant Use Of These Drugs (Posted by Tom Lamb at DrugInjuryWatch.com) On November 30, 2010 the Medicines and Healthcare products Regulatory Agency (MHRA) issued two new safety warnings to doctors and other healthcare providers in the UK concerning the cancer drugs Avastin and Sutent...

First Levaquin Lawsuit Trial In Federal Court MDL Litigation Started In Mid-November 2010

Posted on November 24, 2010
John Schedin v. Johnson and Johnson: Man Ruptured Achilles Tendons In Both Feet After Taking Levaquin (Posted by Tom Lamb at DrugInjuryWatch.com) Back in mid-February 2010 U.S. District Judge John R. Tunheim, who is presiding over the federal court Levaquin multi-district litigation, or MDL -- known as In re: LEVAQUIN PRODUCTS LIABILITY LITIGATION, MDL No...

To access this complete feed in the blog feed reader login or register for free.

North Carolina Aredia / Zometa Product Liability Federal Court Trial Jury Verdict Coming Soon

Posted on November 19, 2010
Plaintiff Alleges Novartis Hid Risks Of Osteonecrosis Jaw-Injury From Rita Fussman And Her Doctors (Posted by Tom Lamb at DrugInjuryWatch.com) A federal court jury which heard the evidence in the three-week trial of the product liability lawsuit Estate of Rita Fussman v...

Zocor Label Change: Interstitial Lung Disease (ILD) Added As Possible Adverse Reaction

Posted on November 15, 2010
November 2010 FDA Approval Of Merck Action Raises Profile Of This Emerging Drug Safety Issue (Posted by Tom Lamb at DrugInjuryWatch.com) As we reported recently, the October 2010 issue of the Canadian Adverse Reaction Newsletter (CARN) included an article titled "Statins and interstitial lung disease"...

Sprint Fidelis Lead Wire Defect Litigation Comes To An Apparent Disappointing End (Medtronic Wins)

Posted on November 10, 2010
8100 Pending Lawsuits Get Modest Settlement Payments; Remaining 100,000 Plus U.S. Patients Have No Legal Claim Due To Federal Preemption Ruling (Posted by Tom Lamb at DrugInjuryWatch.com) As those who have been following the Sprint Fidelis litigation know by now, the thousands of product liability lawsuits that had been filed in connection with the defective lead wire recall by Medtronic did not go the way that injured plaintiffs had hoped...

Health Canada And FDA Issue Adverse Reaction Updates In Second Half Of 2010 Which Involve Popular Drug Zocor (Simvastatin)

Posted on November 05, 2010
Cases Of Interstitial Lung Disease (ILD) And Rhabdomyolysis / Myopathy Associated With Cholesterol Drugs Known As Statins, Including Zocor (Posted by Tom Lamb at DrugInjuryWatch.com) The October 2010 issue of the Canadian Adverse Reaction Newsletter (CARN) included an article "Statins and interstitial lung disease" which began with these two "Key points": During the last 15 years, 29 cases of interstitial lung disease (ILD) suspected of being associated with statins have been published...

Graves v. Merck Fosamax MDL Trial Begins After Pre-trial Motions Rulings By Judge Keenan

Posted on November 02, 2010
Merck Issues Its "No Liability" Press Release On First Day Of Trial; 1092 Fosamax Lawsuits Filed As Of June 2010 (Posted by Tom Lamb at DrugInjuryWatch.com) The trial for the federal court Fosamax MDL case Judith Graves v. Merck & Co., Inc. (No. 1:06-CV-05513-JFK) has started in New York, with Judge John F...

Osteoporosis Medication Aclasta Associated With Renal Impairment And Kidney Failure

Posted on October 25, 2010
Novartis Sends "Dear Doctor" Letter To Canadian Physicians With Health Canada Endorsed Safety Information (Posted by Tom Lamb at DrugInjuryWatch.com) In 2007 Aclasta (zoledronic acid 5mg) was approved by the FDA under the brand name Aclasta� Injection as the first and only once-yearly medicine for postmenopausal osteoporosis...

YAZ And Yasmin MDL: First Trial In Federal Court Set By Judge Herndon To Start September 2011

Posted on October 19, 2010
A Pulmonary Embolism Bellwether Case Will Be Followed By Gallbladder And Venous Thromboembolic Lawsuit Trials (Posted by Tom Lamb at DrugInjuryWatch.com) On October 13, 2010 Judge David Herndon, who is presiding over the federal court YAZ and Yasmin MDL, entered an Order which ended with this statement: Having found that this litigation will benefit from the establishment of bellwether trials, the Court has set firm trial dates and means and method for selecting the cases for trials...

Aredia / Zometa Jaw Injury Lawsuit In New Jersey Ends In Defense Verdict For Novartis

Posted on October 07, 2010
This October 2010 New Jersey Trial Result Is In Stark Contrast To $3.2 Million Verdict In 2009 Montana Zometa Case (Posted by Tom Lamb at DrugInjuryWatch.com) In early October 2010 the New Jersey state court jury which heard the evidence in the case of Bessemer v...

Graves v. Merck Fosamax MDL Trial Jury Verdict Is Expected By End Of November 2010

Posted on September 30, 2010
Two More Fosamax Lawsuits Involving Jaw Injury Like Osteonecrosis Of The Jaw (ONJ) Will Go To Trial In Spring 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) The next scheduled trial in the federal court Fosamax MDL is Judith Graves v. Merck & Co., Inc...

Avandia Recall Decision In Europe To Be Announced On Or About September 23, 2010

Posted on September 22, 2010
Will This September 2010 EMA Committee Meeting Result In A Consensus, Unlike July 2010 FDA Avandia Panel Voting (Posted by Tom Lamb at DrugInjuryWatch.com) The Committee for Medicinal Products for Human Use (CHMP), which has been meeting at the headquarters of the European Medicines Agency (EMA) in London since September 20, 2010, is expected to announce tomorrow, September 23, whether GlaxoSmithKline's diabetes drug Avandia (rosiglitazone) should be recalled in Europe due to its links with heart attacks...

Fosamax Femur Fracture Warning Label Change By Merck Seems Likely After Task Force Report

Posted on September 16, 2010
FDA Considering Issue Due To September 2010 American Society of Bone And Mineral Research Report About Bisphosphate Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) A new task force report on bisphosphonates, like Fosamax (alendronate), and an association with atypical femur fractures in osteoporosis patients has caused the FDA to consider requiring drug companies like Merck to make a label change to increase the warning about this rare but serious side effect...

Will The FDA Follow The EMA And Order A Meridia Recall After Its September 2010 Advisory Committee Meeting

Posted on September 10, 2010
NEJM Editorial: There Should Be A Meridia Recall As The Risk Of Heart-Related Side Effects Is Greater Than Any Weight-Loss Benefit (Posted by Tom Lamb at DrugInjuryWatch.com) According to a recent medical article, "Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects" (Abstract), published September 2, 2010 by the New England Journal of Medicine (NEJM), patients with preexisting cardiovascular conditions who were given the obesity drug Meridia (sibutramine) over a long term had an increased risk of nonfatal myocardial infarction (MI), or heart attack, and nonfatal stroke, but not an increased risk of cardiovascular death or of all-cause...

An Increase In Complications Due To Surgical Revision Of Defective Sprint Fidelis Leads

Posted on August 30, 2010
Lead Wire Extraction Surgery Might Be More Hazardous Than Once Thought, Including Serious Cardiovascular Injuries And Deaths (Posted by Tom Lamb at DrugInjuryWatch.com) The Sprint Fidelis lead wire, a heart defibrillator cable made by Medtronic, was removed from the market in October 2007 due to a defect that caused it to malfunction, which may have resulted in at least five patient deaths...

Digitek MDL Federal Court Judge Goodwin Issues Litigation Stay In August 2010

Posted on August 25, 2010
October 2010 Meeting With State Court Judges Is Postponed; Fate Of Bellwether Cases Uncertain (Posted by Tom Lamb at DrugInjuryWatch.com) On August 12, 2010 U.S. District Court Judge Joseph Goodwin issued Pretrial Order #62 (Re: Stay of Litigation) for the In Re Digitek� Product Liability Litigation, MDL No...

Popular Seizure And Bipolar Disorder Medication Lamictal Associated With Aseptic Meningitis In August 2010

Posted on August 19, 2010
FDA Working With GlaxoSmithKline To Update Label, Or Package Insert, And Patient Medication Guide To Warn About This Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) On August 12, 2010 the FDA announced that Lamictal (lamotrigine), a medication commonly used for seizures in children two years and older as well as for bipolar disorder in adults, can cause aseptic meningitis...

August 2010 Status Update For The Yaz / Yasmin / Ocella Federal Court MDL Litigation

Posted on August 12, 2010
More Than 2600 Lawsuits Have Been Filed To Date; First Trial May Be As Soon As September 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) On August 11, 2010 Judge David R. Herndon held a Status Conference for the Yaz / Yasmin / Ocella federal court multi-district litigation (MDL) -- IN RE YASMIN AND YAZ (DROSPIRENONE) MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION, MDL No...

Mixed Signals About The Safety Of Acme Medication Accutane (Isotretinoin) Continue To Emerge In Summer 2010

Posted on August 06, 2010
FDA Says Accutane Was Not Withdrawn Because Unsafe Drug, While Medical Journal Article Finds Link Between Isotretinoin Therapy And Ulcerative Colitis (Posted by Tom Lamb at DrugInjuryWatch.com) When we last wrote about the acme medication Accutane (isotretinoin), it seemed that there was some momentum growing as regards the idea that Accutane was an unsafe drug, as can seen by this headline: April 2010 Accutane Update: More Medical Evidence Follows A Large Trial Verdict For Drug Injury Victim -- New Study Finds Increased Risk Of Developing Ulcerative Colitis; New Jersey Jury Decides Accutane Caused Man's Inflammatory Bowel Disease In the few...

Mixed Signals About The Safety Of Acne Medication Accutane (Isotretinoin) Continue To Emerge In Summer 2010

Posted on August 06, 2010
FDA Says Accutane Was Not Withdrawn Because Unsafe Drug, While Medical Journal Article Finds Link Between Isotretinoin Therapy And Ulcerative Colitis (Posted by Tom Lamb at DrugInjuryWatch.com) When we last wrote about the acne medication Accutane (isotretinoin), it seemed that there was some momentum growing as regards the idea that Accutane was an unsafe drug, as can seen by this headline: April 2010 Accutane Update: More Medical Evidence Follows A Large Trial Verdict For Drug Injury Victim -- New Study Finds Increased Risk Of Developing Ulcerative Colitis; New Jersey Jury Decides Accutane Caused Man's Inflammatory Bowel Disease In the few...

More Evidence That The Stop-Smoking Drug Chantix Is Linked To Agitation, Aggression, And Violence

Posted on August 03, 2010
New Medical Journal Article Looks At 78 Adverse Event Reports Made To FDA Involving Chantix / Champix (Varenicline) (Posted by Tom Lamb at DrugInjuryWatch.com) We last wrote about the relatively popular smoking cessation drug varenicline -- trade name Chantix in the USA and Champix in Europe and other countries, marketed by Pfizer -- about a year ago, when we reported that it was getting a "black-box" warning about the risk of serious neuropsychiatric symptoms including agitation, depression, suicidal thoughts, and attempted suicide...

Current Use Of Some Popular SSRI Antidepressants May Increase The Risk Of Developing Cataracts

Posted on July 29, 2010
Luvox, Effexor, And Paxil Seem To Have Highest Increased Cataract Risks, But Study Does Not Prove That Any Of These Drugs Cause Cataracts (Posted by Tom Lamb at DrugInjuryWatch.com) An article which appeared in the June 2010 edition of the medical journal Ophthalmology shows that the popular selective serotonin reuptake inhibitors (SSRI) antidepressants Luvox (fluvoxamine), Effexor (venlafaxine), and Paxil (paroxetine) raise the risk of cataracts by 39%, 33%, and 23%, respectively, in patients currently taking these drugs...

Rheumatoid Arthritis Drug Arava Gets Increased Warning For Liver Injury In July 2010

Posted on July 22, 2010
The Bolded Warning About Severe Liver Problems Which Was Added In 2003 Is Replaced By "Black-Box" Warning (Posted by Tom Lamb at DrugInjuryWatch.com) On July 13, 2010 the FDA issued a MedWatch Alert about a new increased warning about the association between the rheumatoid arthritis drug Arava (leflunomide) and severe liver injury...

The European Medicines Agency (EMA) Launches Its New Web Site In July 2010

Posted on July 19, 2010
Similar To The U.S. Food And Drug Administration (FDA), This European Union Agency Approves And Monitors Safety Of Medicines (Posted by Tom Lamb at DrugInjuryWatch.com) The European Medicines Agency (EMA) is an agency of the European Union (EU) which, in part, is responsible for the evaluation and supervision of medicines for human use in Europe, like our FDA does here...

10,000 Avandia Lawsuits Settled For $460 Million While FDA Considers Possible Avandia Recall

Posted on July 13, 2010
During July 13-14, 2010 FDA Advisory Committee Meeting, Glaxo Settles Most Of The 13,000 Avandia Court Cases (Posted by Tom Lamb at DrugInjuryWatch.com) Bloomberg reporters Jef Feeley and Trista Kelley broke the news of a large (in terms of the number of claims, at least) Avandia settlement while most of the media's attention was on the July 13-14, 2010 FDA Advisory Committee meeting about whether Avandia should remain on the market in the U...

A Brief History Of Prescription Drug Recalls In The U.S., 1997-2010

Posted on July 07, 2010
FDA Will Consider Next Possible Market Withdrawl During July 13-14 Hearing About Avandia(Posted by Tom Lamb at DrugInjuryWatch.com) At the end of June 2010 reporter Marilynn Marchione wrote an article, "When is a drug too risky to stay on the market?", that was published by the Associated Press (AP)...

Zithromax (Azithromycin) And Zmax Associated With Liver Failure And Pyloric Stenosis, Respectively

Posted on July 01, 2010
FDA Is Continuing To Evaluate These Emerging Drug-Safety Issues To Determine Whether Any Regulatory Action Is Needed (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-May 2010 we wrote an article "Zithromax-Induced Liver Injury Case Report Where There Was No History Of Liver Problems"...

Boles v. Merck Fosamax Trial Jury Verdict Is $8 Million For Plaintiff In June 2010

Posted on June 26, 2010
This Was A Retrial Of The First Fosamax MDL Case, Which Ended When Judge Declared Mistrial Back In September 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) The case of Boles v. Merck & Co., one of the hundreds of Fosamax jaw injury lawsuits that are combined in the federal court MDL titled In Re Fosamax Products Liability Litigation (MDL 1789, U...

Previous | Next

Related Law Bulletins

Summary Judgement for Dismissal of Personal Injury Lawsuits Require Establishment that Defendant didn't Create the Dangerous Condition of have actual or Constructive Notice of its Existence.
After picking up lunch from the deli counter of a local ...

Ruth’s Chris Steak House Employees in Baltimore, Maryland File $64 Million Personal Injury Lawsuit Over Carbon Monoxide Leak
In Baltimore Circuit Court on Tuesday, 16 Ruth’s Chris Steak Hou...

Brain Injury Caused by Stanley Works Nail Gun Results in $3.4 Million Verdict
A 51 year old construction worker using a Stanley Works nail gun, ...

Bill Proposes to Allow Sex Abuse Victims to File Injury Lawsuits in Maryland
In Maryland, Baltimore County legislator Eric M. Bromwell has intr...

Injury Verdict Upheld in Chicago Police Department Auto Accident
A verdict awarded from a personal injury case in Chicago against t...